[PDF] Top 20 TP53 status and response to treatment in breast cancers.
Has 10000 "TP53 status and response to treatment in breast cancers." found on our website. Below are the top 20 most common "TP53 status and response to treatment in breast cancers.".
TP53 status and response to treatment in breast cancers.
... distribution, and reproduction in any medium, provided the original work is properly ...role in cells as is shown by its fine regulation at different ...described. In breast ... Voir le document complet
10
Triple-negative breast cancer : treatment challenges and solutions
... complete response; CRR, clinical response rate; DFS, disease-free survival; EC, epirubicin–cyclophosphamide; EFS, event-free survival; ETC, epirubicin–paclitaxel–cyclophosphamide; HRD, homologous ... Voir le document complet
15
18F-fluoride PET/CT for assessing bone involvement in prostate and breast cancers
... with breast (n = 24) or prostate (n = 10) cancer at a high risk of BM (mean age ± standard deviation: ...institution and all patients gave informed consent to participate in the ...equal ... Voir le document complet
9
Predictive and prognostic role of peripheral blood eosinophil count in triple negative and hormone receptor negative/HER2 positive breast cancers patients undergoing neoadjuvant treatment.
... rate in patients with ...0.04), and a higher median REC in patients with pCR ...REC and relapse, nor between RLC with pCR or ...high and low REC respectively (p 0.05; HR 0.336, 95% CI ... Voir le document complet
1
Molecular basis of anti-hormonal treatment and resistance in breast cancer
... 4.2 Breast cancer classification Currently using TNM classification for breast tumours is according to their extension of ...elements in this classification are: tumour size, presence of ... Voir le document complet
140
Claudin-low breast cancers: clinical, pathological, molecular and prognostic characterization
... comparatively to the other molecular subtypes at several levels: clinicopathological, genomic, transcriptional, survival, and response to ...receptor status, with a lower frequency of ... Voir le document complet
15
Tumor collagenase stimulatory factor (TCSF) expression and localization in human lung and breast cancers.
... equal to or less than ...RNAzol treatment (Biogenesis; Bournemouth, ...electrophoresis in 1% agarose gels containing 10% formaldehyde and transferred onto ny- lon membranes (Hybond-N; ... Voir le document complet
7
Identification of 5 novel genes methylated in breast and other epithelial cancers.
... cancer. In patients with breast cancer estrogen receptor (ER) status is an important treatment and prognostic ...The response of breast cancer patients to endocrine ... Voir le document complet
14
Kinome expression profiling and prognosis of basal breast cancers.
... immune response, and notably the adaptive cytotoxic T H 1-cell response [47], influence survival of basal BC ...allow to really conclude about the impact of the quantity of lymphocyte ... Voir le document complet
12
Should a Multigene Signature be Used in all Luminal Early Breast Cancers
... chemotherapy in clinical low risk/ genomic high-risk node negative patients? Recently, a PAM50-based chemo-endocrine score was developed and validated to predict tumor sensitivity to ... Voir le document complet
11
Influence of weight status in the response to Step-2 maintenance therapies in children with asthma
... imputations to address missing data for BMI percentile ...exposure to smoking (22.6%) and family income ...differences in baseline characteristics between treat- ment groups, as recommended by ... Voir le document complet
10
Acute osteomyelitis due to Staphylococcus aureus in children: what is the status of treatment today?
... antibiotic treatment. Vancomycin remains the first choice in the treatment of acute MRSA osteomyelitis in ...picture and the epidemi- ological ...myositis and associated pneu- ... Voir le document complet
7
Acute osteomyelitis due to Staphylococcus aureus in children: what is the status of treatment today?
... antibiotic treatment. Vancomycin remains the first choice in the treatment of acute MRSA osteomyelitis in ...picture and the epidemi- ological ...myositis and associated pneu- ... Voir le document complet
6
Safety, Efficacy, and Patient Acceptability of Everolimus in the Treatment of Breast Cancer.
... efficacy and safety in patients treated with everolimus and exemestane according to clinical ...obtained in BOLERO-2. A subgroup analysis was made according to everolimus dos- ... Voir le document complet
14
en fr Challenges of Next Generation Sequencing in the exploration of genetic predispositions to breast and/or ovarian cancers Les défis du séquençage à haut débit dans l'exploration génétique des cancers du sein et de l'ovaire.
... Les cancers du sein et de l’ovaire sont les cancers les plus fréquents chez la femme, et les deuxièmes plus fréquents tous cancers ...exemple TP53, PTEN, STK11 et CDH1 (forte pénétrance), ATM, ... Voir le document complet
259
Stimulated thyroglobulin and Thyroglobulin Reduction Index Predict Excellent Response in Differentiated Thyroid Cancers
... first to describe the general characteristics of the population at ...(median and range if distribution is not Gaussian), and qualitative parameters are described in terms of population size ... Voir le document complet
11
Expression of small breast epithelial mucin (SBEM) protein in tissue microarrays (TMAs) of primary invasive breast cancers
... (ER) and progesterone receptor (PR) are the two most useful clinical markers predicting response to hormonal therapy in both metastatic disease and in the adjuvant ... Voir le document complet
16
Clinicopathologic significance of DNA methyltransferase 1, 3a, and 3b overexpression in Tunisian breast cancers.
... electrophoresis, and the yield was measured spectrophotometrically on a Biophotometer (Eppendorf, Hamburg, Germany) before use and stored at ...designed to amplify a fragment of 407 bp of the ... Voir le document complet
8
Signaling the unfolded protein response in primary brain cancers
... found in children (Rickert and Paulus, ...I), and CP carcinoma (WHO Grade III), which exhibits a worse ...Surgical treatment is the mainstay of the cure of these tumors, however radiation ... Voir le document complet
28
Targeting a cell state common to triple‐negative breast cancers
... counts in the immobilized compound versus free compound competition ...PKC412 treatment impact by means of probabilities resulting from a diffusion process with the targets as ...summing to 1 ... Voir le document complet
17
Sujets connexes